Patents by Inventor Yoann MENON

Yoann MENON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hemi-synthetic trilobine analogs for use as a drug
    Patent number: 10544156
    Abstract: The invention concerns a compound of the following formula (I) or a pharmaceutically acceptable salt or solvate thereof as well as a pharmaceutical composition containing such a compound, and the use of such a compound as a drug, notably as a DNMT inhibitor, in particular in the treatment of cancer.
    Type: Grant
    Filed: October 3, 2016
    Date of Patent: January 28, 2020
    Assignees: PIERRE FABRE MEDICAMENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Ludovic Halby, Yoann Menon, El Bachir Kaloun, Christophe Long, Paola B. Arimondo
  • Trilobine and its natural analogs for use as a drug
    Patent number: 10517863
    Abstract: Trilobine and its natural triple-bridged bisbenzylisoquinoline alkaloidal analogues as DNMT inhibitors for use as a drug for the treatment of cancer and neurological diseases and for cell reprogramming, in particular to prime for chemotherapy or immunotherapy.
    Type: Grant
    Filed: October 3, 2016
    Date of Patent: December 31, 2019
    Assignees: PIERRE FABRE MEDICAMENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Yoann Menon, Christophe Long, François Sautel, Paola B. Arimondo
  • HEMI-SYNTHETIC TRILOBINE ANALOGS FOR USE AS A DRUG
    Publication number: 20190062339
    Abstract: The invention concerns a compound of the following formula (I) or a pharmaceutically acceptable salt or solvate thereof as well as a pharmaceutical composition containing such a compound, and the use of such a compound as a drug, notably as a DNMT inhibitor, in particular in the treatment of cancer.
    Type: Application
    Filed: October 3, 2016
    Publication date: February 28, 2019
    Applicants: PIERRE FABRE MEDICAMENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Ludovic HALBY, Yoann MENON, El Bachir KALOUN, Christophe LONG, Paola B. ARIMONDO
  • TRILOBINE AND ITS NATURAL ANALOGS FOR USE AS A DRUG
    Publication number: 20180280379
    Abstract: Trilobine and its natural triple-bridged bisbenzylisoquinoline alkaloidal analogues as DNMT inhibitors for use as a drug for the treatment of cancer and neurological diseases and for cell reprogramming, in particular to prime for chemotherapy or immunotherapy.
    Type: Application
    Filed: October 3, 2016
    Publication date: October 4, 2018
    Applicants: PIERRE FABRE MEDICAMENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Yoann MENON, Christophe LONG, François SAUTEL, Paola B. ARIMONDO